Drug reform – Benefits Canada.com https://uat-cumulus.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Thu, 16 Jan 2025 20:41:36 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 How is the pandemic, policy issues impacting group benefits and pharmaceutical industries? https://uat-cumulus.benefitscanada.com/benefits/health-benefits/how-is-the-pandemic-policy-issues-impacting-group-benefits-and-pharmaceutical-industries/ Mon, 22 Nov 2021 14:00:25 +0000 https://www.benefitscanada.com/?p=112065 The proposed amendments to the patented medicines regulations by the Patented Medicine Prices Review Board could have a big impact on both the group insurance and pharmaceutical industry. “The CLHIA is very supportive of PMPRB adjustments that may be coming,” said Joan Weir, director of health and disability policy at the Canadian Life and Health […]

The post How is the pandemic, policy issues impacting group benefits and pharmaceutical industries? appeared first on Benefits Canada.com.

]]> NDP promising universal pharmacare, Conservatives looking to double EI sickness benefits https://uat-cumulus.benefitscanada.com/benefits/health-benefits/ndp-promising-universal-pharmacare-conservatives-looking-to-double-ei-sickness-benefits/ Mon, 30 Aug 2021 19:00:11 +0000 https://www.benefitscanada.com/?p=106481 If elected, New Democratic Party Leader Jagmeet Singh is pledging to begin working with provinces immediately to deliver a single-payer, public pharmacare program for all Canadians. The NDP say millions of people can’t afford to take the medications they need and must skip doses, cut their pills in half or even go without them. “We […]

The post NDP promising universal pharmacare, Conservatives looking to double EI sickness benefits appeared first on Benefits Canada.com.

]]> Possible national pharmacare program has pros, cons for employers: experts https://uat-cumulus.benefitscanada.com/benefits/health-benefits/possible-national-pharmacare-program-has-pros-cons-for-employers-experts/ Wed, 18 Aug 2021 13:00:51 +0000 https://www.benefitscanada.com/?p=105876 Discussion around implementing a national universal pharmacare strategy is growing louder ahead of next month’s federal election. In its 2019 budget, the federal government said it would work with partners to move forward on a national pharmacare program, including the creation of a new national drug agency and formulary, as well as a national strategy for […]

The post Possible national pharmacare program has pros, cons for employers: experts appeared first on Benefits Canada.com.

]]> Head to head: Should private drug plans require biosimilar non-medical switching? https://uat-cumulus.benefitscanada.com/archives_/benefits-canada-archive/head-to-head-should-private-drug-plans-require-biosimilar-non-medical-switching/ Fri, 13 Aug 2021 12:59:32 +0000 https://www.benefitscanada.com/?p=105123 While one side highlights how plan sponsors can contribute to biosimilar sustainability, the other touts the benefits to patients and the health-care system. Durhane Wong-Rieger, president and chief executive officer, Institute for Optimizing Health Outcomes The Institute for Optimizing Health Outcomes recently published a scorecard rating the biosimilar policy frameworks of European countries across seven […]

The post Head to head: Should private drug plans require biosimilar non-medical switching? appeared first on Benefits Canada.com.

]]> CLHIA calling for increased access to VPLAs, prescription drugs https://uat-cumulus.benefitscanada.com/pensions/governance-law/clhia-calling-for-increased-access-to-vplas-prescription-drugs/ Mon, 09 Aug 2021 19:00:32 +0000 https://www.benefitscanada.com/?p=105272 The Canadian Life and Health Insurance Association is calling on the federal government to permit standalone variable payment life annuities to pool participants from all registered retirement plans. In its 2022 federal budget submission, the CLHIA said VPLAs, as enacted, will only be available to members of very large defined contribution pension plans, excluding Canadians […]

The post CLHIA calling for increased access to VPLAs, prescription drugs appeared first on Benefits Canada.com.

]]> Expert panel: A look at retiree benefits and the current health-care system https://uat-cumulus.benefitscanada.com/expertpanel_/claude-marchessault/expert-panel-a-look-at-retiree-benefits-and-the-current-health-care-system/ Tue, 20 Jul 2021 13:00:31 +0000 https://www.benefitscanada.com/?p=104175 Many employees may be dreaming of a carefree retirement following many years in the trenches — but they’ll likely have to keep dreaming if they don’t have first-rate, post-retirement health and dental insurance coverage. Many employers provide supplemental health insurance (drug, dental, extended health and out-of-country medical) as part of comprehensive packages of employee benefits, […]

The post Expert panel: A look at retiree benefits and the current health-care system appeared first on Benefits Canada.com.

]]> Pharmacare should include high-cost treatment strategy, flexibility for plan sponsors: consultant https://uat-cumulus.benefitscanada.com/news/bencan/pharmacare-should-include-high-cost-treatment-strategy-flexibility-for-plan-sponsors-consultant/ Thu, 22 Apr 2021 13:00:27 +0000 https://www.benefitscanada.com/?p=99002 While a national pharmacare program is yet to be revealed by the federal government, any future plan should contain provisions for all costly treatments and not just rare diseases, says Jennifer Schmidt, a principal at Mercer Canada. Read: Federal budget highlights national childcare system, extension of pandemic subsidies This week’s federal budget announcement contained only […]

The post Pharmacare should include high-cost treatment strategy, flexibility for plan sponsors: consultant appeared first on Benefits Canada.com.

]]> High-cost drugs remain primary cost driver for Canadian public, private drug plans: PMPRB https://uat-cumulus.benefitscanada.com/news/bencan/high-cost-drugs-remain-primary-cost-driver-for-canadian-public-and-private-drug-plans-pmprb/ Thu, 01 Apr 2021 13:00:52 +0000 https://www.benefitscanada.com/?p=97594 High-cost drugs remain the primary cost driver for Canadian public and private drug plans, said the Patented Medicine Prices Review Board’s newly released 2019 annual report. Patty Hajdu, the federal government’s minister of health, tabled the report, which found the sales of patented drugs grew 3.5 per cent to over $17 billion in 2019. Additionally, […]

The post High-cost drugs remain primary cost driver for Canadian public, private drug plans: PMPRB appeared first on Benefits Canada.com.

]]> Employers should rethink approach to helping employees with obesity https://uat-cumulus.benefitscanada.com/benefits/health-benefits/employers-should-rethink-approach-to-helping-employees-with-obesity/ Fri, 15 Jan 2021 04:58:32 +0000 https://cumulus.benefitscanada.com/uncategorized/employers-should-rethink-approach-to-helping-employees-with-obesity/ Employers that don’t cover obesity drugs should ask themselves why, said Noel McKay, principal consultant at Cowan Insurance Group, during Benefits Canada’s Face to Face Drug Plan Management Forum on Dec. 9, 2020. “Is the risk of driving up benefits costs the reason? If so, I don’t think you have to fear it. Maybe two […]

The post Employers should rethink approach to helping employees with obesity appeared first on Benefits Canada.com.

]]> Drug pricing reforms may impact Canadians’ access to medications https://uat-cumulus.benefitscanada.com/benefits/health-benefits/drug-pricing-reforms-may-impact-access-to-medication/ Fri, 15 Jan 2021 04:57:58 +0000 https://cumulus.benefitscanada.com/uncategorized/drug-pricing-reforms-may-impact-access-to-medication/ Despite concerns Canadian drug prices are skyrocketing, the Patented Medicines Price Review Board, Canada’s price regulator, has ensured costs for patented drugs haven’t increased more than the Canadian Consumer Price Index in close to 30 years, said Wayne Critchley, Global Public Affairs’ senior associate of health and life sciences, during Benefits Canada’s Face to Face […]

The post Drug pricing reforms may impact Canadians’ access to medications appeared first on Benefits Canada.com.

]]>